Product Information
DICLOXACILLIN 250 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.5749 per EA under NDC 00093312301. Its NADAC has been published 622 times since Nov 28, 2013.
Strength
250 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093312301
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DICLOXACILLIN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA062286On Market Since
9/30/1990
Pharmacological Classes
Price Statistics
The NADAC for DICLOXACILLIN 250 MG CAPSULE has been published 622 times since Nov 28, 2013, and over the history we have for it it has risen 165.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5749 per EA |
|---|---|
| All-time high | $0.6096 (Oct 16, 2019) |
| All-time low | $0.2167 (Nov 28, 2013) |
| 52-week high | $0.6071 |
| 52-week low | $0.5112 |
| Median price | $0.4684 |
| Average price | $0.4344 |
| Largest weekly change | +59.7% (Jul 20, 2016) |
| Weeks tracked | 622 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Dicloxacillin Sodium market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of DICLOXACILLIN 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DICLOXACILLIN 250 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $0.5749 per EA (NDC 00093312301), effective Jun 24, 2026.
How has the price of DICLOXACILLIN 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for DICLOXACILLIN 250 MG CAPSULE has risen 165.3%. It has been tracked across 622 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DICLOXACILLIN 250 MG CAPSULE?
Since Nov 28, 2013, the NADAC for DICLOXACILLIN 250 MG CAPSULE has ranged from a low of $0.2167 (Nov 28, 2013) to a high of $0.6096 (Oct 16, 2019), with a median of $0.4684 per EA.
Are there cheaper alternatives to DICLOXACILLIN 250 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DICLOXACILLIN 250 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures DICLOXACILLIN 250 MG CAPSULE?
DICLOXACILLIN 250 MG CAPSULE (NDC 00093312301) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification